Seebri Breezhaler

Seebri Breezhaler

glycopyrronium bromide

Manufacturer:

Novartis

Distributor:

Zuellig
/
Four Star
Concise Prescribing Info
Contents
Glycopyrronium Br
Indications/Uses
Maintenance bronchodilator treatment to relieve symptoms in adult patients w/ COPD.
Dosage/Direction for Use
Special Precautions
Not for acute use. Discontinue in case of immediate hypersensitivity reactions; paradoxical bronchospasm. Use w/ caution in patients w/ narrow-angle glaucoma or urinary retention; severe renal impairment; history of CV disease. Patients w/ rare hereditary problems (galactose intolerance, Lapp lactase deficiency or galactose malabsorption). Pregnancy & lactation.
Adverse Reactions
Nasopharyngitis; insomnia; headache; dry mouth, gastroenteritis; UTI.
Drug Interactions
Not recommended w/ anticholinergic-containing drugs.
MIMS Class
Antiasthmatic & COPD Preparations
ATC Classification
R03BB06 - glycopyrronium bromide ; Belongs to the class of other inhalants used in the treatment of obstructive airway diseases, anticholinergics.
Presentation/Packing
Form
Seebri Breezhaler inhalation powd cap 50 mcg (+ inhaler)
Packing/Price
30's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in